icons icons icons

Living with an invisible illness: how to talk about cystic fibrosis.

Prime Medicine receives $24 million to develop gene-editing therapy for cystic fibrosis

New targeted drug Alyftrek from Vertex Pharmaceuticals

Effect of ELX/TEZ/IVA on infections and antibiotic use in cystic fibrosis.

Results from the European Congress ECFS 2025.

European Congress on Cystic Fibrosis (ECFS 2025)

Officially approved: Zaporizhia Regional Hospital became a Reference Orphan Center

Iron deficiency anemia in cystic fibrosis.

Long-term efficacy of cystic fibrosis treatment with dual CFTR modulator

Magnesium and Calcium in Cystic Fibrosis: Why It’s Important to Monitor Micronutrient Levels